ABVC Biopharma

ABVC · NASDAQ

$0.93+$0.02 (+2.20%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $0.91

About ABVC

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The company is headquartered in Fremont, California and currently employs 19 full-time employees. The company went IPO on 2004-11-09. The firm is focused on the development of new drugs and medical devices, all of which are derived from plants. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1702, ABV-1703, ABV-1501, and ABV-1701. The firm is developing and researching ABV-1504, a botanical reuptake inhibitor that targets norepinephrine. ABV-1505 to treat attention deficit hyperactivity disorder (ADHD). The company has developed ABV-1601 for treating depression in cancer patients. ABV-1702 to treat Myelodysplastic syndromes. The company has developed an indication for pancreatic cancer from maitake extract, named ABV-1703. ABV-1501 for the treatment of Triple Negative Breast Cancer. ABV-1701 Vitargus for the treatment of Retinal Detachment or Vitreous Hemorrhage. ABV-1519 for the treatment of Non-Small Cell Lung Cancer.

Employees: 19
Headquarters: Fremont, California
Listed: Nov 9, 2004
Sector: Health Care
Industry: Biotechnology
Website: abvcpharma.com

Leadership

ABVC Biopharma executives
Name	Title	Since	Age
Eugene Jiang	—	2015	38
Uttam Patil	—	—	39
Tsung-Shann Jiang	—	2018	71
Chang-Jen Jiang	—	—	69
Shuling Jiang	—	—	69
Tsang Ming Jiang	—	—	64
Yen-Hsin Chou	—	—	36
Yu- Min Chung	—	—	60
Che-Wei Hsu	—	—	43
Hsin-Hui Miao	—	—	59
Yoshinobu Odaira	—	—	77
Norimi Sakamoto	—	—	54

Similar companies

Companies in the same industry as ABVC Biopharma

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.